EAM
EVH icon

Eagle Asset Management’s Evolent Health EVH Stock Holding History

Eagle Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$387K Sell
29,001
-616,845
-96% -$15.9M ﹤0.01% 516
2024
Q2 		$11.9M Sell
645,846
-128,706
-17% -$3.29M 0.06% 257
2024
Q1 		$24.7M Sell
774,552
-34,988
-4% -$1.12M 0.13% 164
2023
Q4 		$26.7M Buy
809,540
+76,168
+10% +$2.16M 0.14% 157
2023
Q3 		$20M Sell
733,372
-55,915
-7% -$1.55M 0.12% 181
2023
Q2 		$23.9M Sell
789,287
-309,969
-28% -$10M 0.13% 165
2023
Q1 		$35.7M Sell
1,099,256
-272,347
-20% -$8.61M 0.21% 133
2022
Q4 		$37M Sell
1,371,603
-119,661
-8% -$3.43M 0.23% 134
2022
Q3 		$53.6M Buy
1,491,264
+246,542
+20% +$8.69M 0.35% 102
2022
Q2 		$38.2M Buy
1,244,722
+284,084
+30% +$8.28M 0.24% 137
2022
Q1 		$31M Sell
960,638
-813,083
-46% -$21.3M 0.16% 160
2021
Q4 		$49.1M Sell
1,773,721
-676,353
-28% -$19.4M 0.22% 151
2021
Q3 		$76M Sell
2,450,074
-50,069
-2% -$1.2M 0.34% 113
2021
Q2 		$52.8M Sell
2,500,143
-879,918
-26% -$17.6M 0.23% 150
2021
Q1 		$69.9M Sell
3,380,061
-66,572
-2% -$1.27M 0.31% 125
2020
Q4 		$55.2M Buy
3,446,633
+79,447
+2% +$1.05M 0.31% 111
2020
Q3 		$43.3M Buy
3,367,186
+473,676
+16% +$5.57M 0.22% 158
2020
Q2 		$19.8M Sell
2,893,510
-245,350
-8% -$1.64M 0.11% 214
2020
Q1 		$17M Sell
3,138,860
-274,515
-8% -$2.45M 0.11% 220
2019
Q4 		$30.9M Buy
3,413,375
+410,895
+14% +$3.34M 0.15% 207
2019
Q3 		$21.6M Buy
3,002,480
+1,149,789
+62% +$8.25M 0.11% 224
2019
Q2 		$14.7M Sell
1,852,691
-387,867
-17% -$4.59M 0.08% 255
2019
Q1 		$28.2M Sell
2,240,558
-107,154
-5% -$1.7M 0.15% 210
2018
Q4 		$46.8M Sell
2,347,712
-193,125
-8% -$4.47M 0.29% 138
2018
Q3 		$72.2M Sell
2,540,837
-33,343
-1% -$795K 0.35% 103
2018
Q2 		$54.2M Buy
2,574,180
+582,666
+29% +$11M 0.29% 133
2018
Q1 		$28.4M Sell
1,991,514
-37,676
-2% -$539K 0.15% 204
2017
Q4 		$25.1M Buy
2,029,190
+499,247
+33% +$7.04M 0.14% 221
2017
Q3 		$28.6M Buy
1,529,943
+442,058
+41% +$9.11M 0.16% 213
2017
Q2 		$27.6M Buy
+1,087,885
New +$26.2M 0.17% 204

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Eagle Asset Management's EVH Position: Q3 2024 in Review

Eagle Asset Management reduced its Evolent Health (EVH) stake by 96% in Q3 2024, selling an estimated $15.9M and leaving 29,001 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #516.

Eagle Asset Management first reported a position in EVH in Q2 2017 and has held it in 30 quarters since. The position peaked at $76M in Q3 2021. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • Eagle Asset Management held 29,001 shares of Evolent Health worth $387K as of Q3 2024.
  • Eagle Asset Management sold 616,845 Evolent Health shares in Q3 2024, an estimated $15.9M.
  • Evolent Health made up ﹤0.01% of Eagle Asset Management's portfolio in Q3 2024, its #516 holding.
  • Eagle Asset Management first reported a position in Evolent Health in Q2 2017 and has held it in 30 quarters since.
  • Eagle Asset Management's Evolent Health position peaked at $76M in Q3 2021.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.